[Lactobacillus rhamnosus septicemia in a diabetic patient associated with probiotic use: a case report]

Ann Biol Clin (Paris). 2008 Mar-Apr;66(2):195-8. doi: 10.1684/abc.2008.0210.
[Article in French]

Abstract

Background: probiotic agents are increasingly used as over the counter drugs for the treatment of a variety of inflammatory and infectious conditions. The rationale of their use seems to restore a friendly bacterial flora in the gut. Complications of probiotic use, although rarely reported, can occur.

Observation: we describe the case of a 54-year-old diabetic woman, who developed Lactobacillus rhamnosus septicemia while she was using probiotic oral treatment. Lactobacillus is a major component of probiotic agents. Her infection resolved after amoxicilline administration.

Discussion: this case highlights the complication of probiotic use, and perhaps the patient's predispositions to develop such complications.

Publication types

  • Case Reports
  • Comparative Study
  • English Abstract

MeSH terms

  • Administration, Oral
  • Amoxicillin / administration & dosage
  • Amoxicillin / therapeutic use
  • Diabetes Mellitus, Type 2 / complications*
  • Female
  • Humans
  • Lacticaseibacillus rhamnosus* / isolation & purification
  • Middle Aged
  • Probiotics / adverse effects*
  • Sepsis / drug therapy
  • Sepsis / etiology
  • Sepsis / microbiology*
  • Time Factors
  • Treatment Outcome

Substances

  • Amoxicillin